Narula N, Hamam H. Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases: The Powerful Pill. Can IBD Today [Internet]. 2023 Nov. 23 [cited 2024 Nov. 21];1(S11):2–11. Available from: https://canadianibdtoday.com/article/view/1-s11-narula_hamam